CCWM
TEVA icon

Cassaday & Co Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Cassaday & Co Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.32K Buy
275
+200
+267% +$6.66K ﹤0.01% 881
2026
Q1 		$2.26K Buy
+75
New +$2.41K ﹤0.01% 1055

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Cassaday & Co Wealth Management's TEVA Position: Q2 2026 in Review

Cassaday & Co Wealth Management increased its Teva Pharmaceuticals (TEVA) stake by 267% in Q2 2026, buying an estimated $6.66K and bringing the position to 275 shares worth $9.32K. The position accounts for ﹤0.01% of the portfolio, ranked #881.

Cassaday & Co Wealth Management first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Cassaday & Co Wealth Management held 275 shares of Teva Pharmaceuticals worth $9.32K as of Q2 2026.
  • Cassaday & Co Wealth Management bought 200 Teva Pharmaceuticals shares in Q2 2026, an estimated $6.66K.
  • Teva Pharmaceuticals made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #881 holding.
  • Cassaday & Co Wealth Management first reported a position in Teva Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.